Answers are grounded in this paper and cite their sources.
This study demonstrates the effectiveness of ovarian transposition and assisted reproductive technology in preserving reproductive function in cancer patients, indicating improved fertility outcomes.
A total of 624,835 cases of malignant neoplasms were registered in 2023 in the Russian Federation (283,179 and 341,656 cases in male and female patients, respectively). The share of malignant reproductive system neoplasms in the structure of cancer incidence among females. Among those, uterine body cancer is the third in the structure of cancer incidence in Russia and the first among gynecological cancers. Cervical cancer is the eighth in the structure of cancer incidence in Russia. With the improvement of cancer therapy, improvement of the patients’ quality of life, fertility preservation and restoration in patients with reproductive cancer become relevant. Current evidence supports high efficacy of ovarian transposition in preserving the function of the ovaries in patients undergoing pelvic radiotherapy. This method demonstrates the best rate of fertility restoration compared to alternative approaches.
No takes yet. Share an insight, caveat, or question.
Kiseleva et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: